NLS Collaboration

Swedish SyntheticMR and Siemens Healthineers have entered into a cooperation agreement, making the SyMRI software packages from SyntheticMR compatible with MRI scanners from Siemens Healthineers and available to their customers. “I am very pleased to be able to present Siemens Healthineers, one of the globally market leading MRI vendors, as a partner to SyntheticMR. Through […]

Nordic Nanovector has entered into a collaboration with Heidelberg Pharma, a subsidiary of biopharmaceutical company WILEX specializing in the development of antibody-drug conjugates (ADCs), to develop novel ADCs for treating leukaemias. This collaboration is part of Nordic Nanovector’s strategy to develop its pipeline of targeted therapies to include antibody products conjugated to anti-cancer compounds that […]

Ferring Pharmaceuticals and North Zealand University Hospital (Nordsjællands Hospital) have formally inaugurated a multi-year collaboration aimed at transforming the way in which patients with inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS) manage their condition and receive medical care. During the event, held at North Zealand University Hospital in Copenhagen, local doctors, researchers and IBD […]

Amgen and Nuevolution have entered into a multiple target research collaboration to develop and commercialize novel therapeutics in the areas of oncology and neuroscience. Nuevolution will apply its Chemetics drug discovery platform to discover and advance potential therapeutics of interest to Amgen. The research collaboration brings together Nuevolution’s proprietary drug discovery platform with Amgen’s disease […]

Karolinska Development announces that its portfolio company BioArctic has entered into a strategically important collaboration with AbbVie, a global biopharmaceutical company, to develop and commercialize BioArctic’s portfolio of antibodies directed against alpha-synuclein for the treatment of Parkinson’s disease and other potential indications. Parkinson’s disease is the second most-common neurological disease, affecting more than 10 million […]

Profil Institute for Clinical Research and Antaros Medical form strategic alliance to incorporate ddvanced functional imaging techniques into cardiometabolic clinical research. Profil Institute for Clinical Research, Inc., a clinical research organization (CRO) focused exclusively on metabolic diseases, and Antaros Medical has announced a strategic collaboration to apply a broad range of noninvasive PET/MRI imaging techniques into pre- and postmarketing […]